Phase I, Multiple Oral Dose Study to Evaluate the Tolerability and Pharmacokinetics of Favipiravir in Healthy Volunteers

Status

Unknown

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222606

Enrollment

Registered

2014-09-20

Start date

2014-09-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteer

Interventions

investigational material(s) Generic name etc : favipiravir INN of investigational material : favipiravir Therapeutic category code : 629 Other chemotherapeutics Dosage and Administration for Investiga

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy adult volunteers

Exclusion criteria

Exclusion criteria: Patients with a medical history which could influence on the evaluation of safety and pharmacokinetics

Design outcomes

Primary

Measure	Time frame
Safety, pharmacokinetics Safety, pharmacokinetics	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026